Issue: October 2017

Read more

October 06, 2017
4 min read
Save

Concomitant ALL reconstruction yielded significantly reduced ACL graft rupture rate

The rate of ACL graft failure did not differ for isolated quadrupled hamstring tendon grafts and bone-patellar tendon-bone grafts.

Issue: October 2017
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Patients who underwent ACL reconstruction with a hamstring tendon graft combined with anterolateral ligament reconstruction experienced a lower rate of graft failure and had greater odds of returning to their preinjury levels of sport, according to results of a prospective study.

“The main message of this study is that performing anterolateral ligament (ALL) reconstruction at the same time as ACL reconstruction is associated with significantly lower graft rupture rates than with isolated ACL reconstruction using either one of the two most frequently used graft choices in contemporary practice,” Bertrand Sonnery-Cottet, MD, of Centre Orthopédique Santy, FIFA Medical Center of Excellence in Lyon, France, told Orthopedics Today.

Lower graft failure rate

Bertrand Sonnery-Cottet, MD
Bertrand Sonnery-Cottet

Sonnery-Cottet and his colleagues conducted a prospective study of 502 patients (72.5% were men) who underwent primary ACL reconstruction with either a bone-patellar tendon-bone (BPTB) graft, a quadrupled hamstring (HS) tendon graft or a HS tendon graft combined with ALL reconstruction. To identify prognosticators of graft rupture and return to sport, researchers analyzed survivorship data from the Kaplan-Meier analysis using multivariate Cox regression models.

The mean preoperative and postoperative subjective IKDC scores, side-to-side laxity and postoperative Lysholm and Tegner scores were not significantly different between the groups, investigators noted. At a mean follow-up of 38.4 months, the graft rupture rates were 10.77%, 16.77% and 4.13%, respectively, for quadrupled HS tendon grafts, BPTB grafts and HS tendon grafts combined with ALL reconstruction.

The researchers found no significant difference in graft failure rates between isolated quadrupled HS tendon grafts and BPTB grafts. However, in multivariate analysis, HS tendon grafts combined with ALL reconstruction had a rate of graft failure that was 2.5-times less than BPTB grafts and 3.1-times less than quadrupled HS tendon grafts.

Independent variables and failure

Independent variables associated with increased risk of graft failure included patient age of 25 years or younger and preoperative side-to-side laxity greater than 7 mm.

Hamstring tendon grafts combined with ALL reconstruction were associated with greater odds of returning to the pre-injury level of sports when compared with quadrupled HS tendon grafts, but not when compared with BPTB grafts, the researchers noted.

Sonnery-Cottet said the results of this study have shown that not only does the current, anatomic ALL reconstruction have a low reoperation rate due to graft rupture-related and non-graft rupture-related indications, it also does not have the excessively high reoperation rate that has been shown to be associated with non-anatomical lateral extra-articular tenodeses.

“The lack of specific complications of anatomic ALL reconstruction coupled with excellent results leads us to question whether concomitant ALL reconstruction should be considered for all patients undergoing ACL reconstruction,” Sonnery-Cottet said.

PAGE BREAK

However, he and his colleagues have begun a prospective randomized study to address the limitations of this latest study. Another goal of this next study, is to “confirm the significant improvement of graft rupture rates and return to sport with an additional ALL reconstruction compared to an isolated ACL reconstruction,” Sonnery-Cottet said. – by Casey Tingle

Disclosure: Sonnery-Cottet reports he receives royalties from, is a paid consultant for, receives research support from and has made presentations for Arthrex.